EMB07

Clinical trials for EMB07 explained in plain language.

Never miss a new study

Get alerted when new EMB07 trials appear

Sign up with your email to follow new studies for EMB07, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New drug combo targets Tough-to-Treat lymphoma

Disease control Not yet recruiting

This early-stage study is testing a new drug called EMB-07, given in combination with other therapies, for adults with aggressive B-cell non-Hodgkin lymphoma. The main goals are to find a safe dose and see if the treatment can shrink tumors. It will enroll about 115 people, inclu…

Matched conditions: EMB07

Phase: PHASE1, PHASE2 • Sponsor: Shanghai EpimAb Biotherapeutics Co., Ltd. • Aim: Disease control

Last updated Apr 02, 2026 02:42 UTC

EMB07

Get alerted when new EMB07 trials appear

New drug combo targets Tough-to-Treat lymphoma